Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second

被引：0
|
作者：
Kim, Jin-Hyo [1 ]
Park, Sung-Soo [1 ]
Yoon, Jae-Ho [1 ]
Lee, Sung-Eun [1 ]
Kim, Hee-Je [1 ]
Min, Chang-Ki [1 ]
机构：
[1] Catholic Univ Korea, Seoul St Marys Hematol Hosp, Coll Med, Dept Hematol, 222 Banpodaero, Seoul 06591, South Korea
来源：
BLOOD RESEARCH | 2022年 / 57卷 / 01期
关键词：
CD38;
D O I：
10.5045/br.2022.2021183
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：76 / 80
页数：5
相关论文
共 50 条
  • [1] Daratumumab monotherapy in heavily pretreated Asians patients with relapsed and refractory multiple myeloma
    Yoon, Sung-Soo
    Byun, Ja Min
    Park, Hyunkyung
    Lee, Ji Yun
    Koh, Youngil
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E155 - E156
  • [2] Clinical Efficacy of Daratumumab Monotherapy in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma
    Usmani, Saad
    Weiss, Brendan
    Bahlis, Nizar J.
    Belch, Andrew
    Lonial, Sagar
    Lokhorst, Henk
    Voorhees, Peter M.
    Richardson, Paul G.
    Sasser, A. Kate
    Axel, Amy
    Feng, Huaibao
    Uhlar, Clarissa
    Wang, Jianping
    Khan, Imran
    Ahmadi, Tahamtan
    Nahi, Hareth
    BLOOD, 2015, 126 (23)
  • [3] Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma
    Usmani, Saad Z.
    Weiss, Brendan M.
    Plesner, Torben
    Bahlis, Nizar J.
    Belch, Andrew
    Lonial, Sagar
    Lokhorst, Henk M.
    Voorhees, Peter M.
    Richardson, Paul G.
    Chari, Ajai
    Sasser, A. Kate
    Axel, Amy
    Feng, Huaibao
    Uhlar, Clarissa M.
    Wang, Jianping
    Khan, Imran
    Ahmadi, Tahamtan
    Nahi, Hareth
    BLOOD, 2016, 128 (01) : 37 - 44
  • [4] DARATUMUMAB IN MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL CLINICAL PRACTICE IN CATALONIA
    Moreno, David Fernando
    Gomez-Hernando, Marta
    Clapes, Victoria
    Soler, Juan Alfons
    Gonzalez-Montes, Yolanda
    Gironella, Mercedes
    Motllo, Cristina
    Granell, Miquel
    Abella, Eugenia
    Garcia-Pintos, Marta
    Garcia-Guinon, Antoni
    Cabezudo, Elena
    Rosinol, Laura
    HAEMATOLOGICA, 2020, 105 : 138 - 139
  • [5] A new monoclonal antibody, Daratumumab monotherapy in the treatment of refractory or relapsed multiple myeloma
    Richez, Valentine
    Legros, Laurence
    Leleu, Xavier
    HEMATOLOGIE, 2015, 21 (05): : 260 - 261
  • [6] ECONOMIC EVALUATION OF DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Salazar, A.
    Guirant Corpi, L.
    Aguirre, A.
    Herrera, M.
    Chacon, C.
    VALUE IN HEALTH, 2018, 21 : S254 - S254
  • [7] Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma
    Gasparetto, Cristina
    Lentzsch, Suzanne
    Schiller, Gary
    Callander, Natalie
    Tuchman, Sascha
    Chen, Christine
    White, Darrell
    Kotb, Rami
    Sutherland, Heather
    Sebag, Michael
    Baljevic, Muhamed
    Bensinger, William
    Leblanc, Richard
    Venner, Chris
    Bahlis, Nizar
    Rossi, Adriana
    Biran, Noa
    Sheehan, Heidi
    Saint-Martin, Jean-Richard
    Van Domelen, Dane
    Kai, Kazuharu
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael
    Lipe, Brea
    EJHAEM, 2021, 2 (01): : 56 - 65
  • [8] Is There a Role for Daratumumab Retreatment in Patients with Relapsed/Refractory Multiple Myeloma?
    Galusic, Davor
    Krecak, Ivan
    Blaslov, Viktor
    Opara, Andela Krstulovic
    Valkovic, Toni
    Kinda, Sandra Basic
    BIOMEDICINES, 2025, 13 (01)
  • [9] Results of an Early Access Treatment Protocol of Daratumumab Monotherapy in Spanish Patients With Relapsed or Refractory Multiple Myeloma
    Alegre, Adrian
    de la Rubia, Javier
    Sureda Balari, Anna
    Encinas Rodriguez, Cristina
    Suarez, Alexia
    Jesus Blanchard, Maria
    Bargay Lleonart, Joan
    Rodriguez-Otero, Paula
    Insunza, Andres
    Palomera, Luis
    Jesus Penarrubia, Maria
    Rios-Tamayo, Rafael
    Casado Montero, Luis Felipe
    Sonia Gonzalez, Marta
    Potamianou, Anna
    Couturier, Catherine
    Pei, Huiling
    Hevia, Henar
    Milionis, Iordanis
    Gaudig, Maren
    Mateos, Maria-Victoria
    HEMASPHERE, 2020, 4 (03):
  • [10] Efficacy of daratumumab monotherapy in real-world heavily pretreated patients with relapsed or refractory multiple myeloma
    Salomon-Perzynski, Aleksander
    Walter-Croneck, Adam
    Usnarska-Zubkiewicz, Lidia
    Dytfeld, Dominik
    Zielinska, Patrycja
    Wojciechowska, Malgorzata
    Holojda, Jadwiga
    Robak, Pawel
    Pasternak, Anna
    Knopinska-Posluszny, Wanda
    Hawrylecka, Dorota
    Wojtowicz, Marcin
    Szeremet, Agnieszka
    Osowiecki, Michal
    Mordak-Domagala, Monika
    Zaucha, Jan Maciej
    Giannopoulos, Krzysztof
    Warzocha, Krzysztof
    Jamroziak, Krzysztof
    ADVANCES IN MEDICAL SCIENCES, 2019, 64 (02): : 349 - 355
12345